Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  November 10, 2010

CHINA MEDICINE CORPORATION
(Exact name of registrant as specified in Charter)

Nevada
000-51379
51-0539830
(State of Incorporation)
(Commission File Number)
 (IRS Employer
Identification No.)

2/F, Guangri Tower
No. 9 Siyounan Road 1st Street
Yuexiu District
Guangzhou, China 510600
(Address of registrant’s principal executive office)

(8620) 8739-1718 and (8620) 8737-8212
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below in the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240. 14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 2.02
Results of Operations and Financial Condition

On November 10, 2010, the registrant issued a press release announcing (i) certain financial results for the fiscal quarter ended September 30, 2010; (ii) full year financial guidance for the year 2010; and (iii) a conference call to be held by the registrant on Thursday, November 11, 2010 at 8:00 a.m. Eastern Time to discuss the results of operations for the quarter ended September 30, 2010.  A copy of the press release is attached hereto as Exhibit 99.1.

Item 9.01
Financial Statements and Exhibits

(d) Exhibits

Exhibit
Number
  
Description
     
99.1
  
Press Release of China Medicine Corporation, dated November 10, 2010
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
CHINA MEDICINE CORPORATION
  
       
 
By:
/s/ Senshan Yang
  
   
Name:  Senshan Yang
  
   
Title:    Chief Executive Officer
  
       

Date:  November 10, 2010